Jun Iwamoto Yoshihiro Sato Mitsuyoshi Uzawa Hideo Matsumoto
10.2147/TCRM.S38404
Ther Clin Risk Manag
2013;9:1-7.
alendronate bone mineral density etidronate fragility fracture osteogenesis imperfecta
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/23293527/
Case Reports
PMC3534324
23293527
Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I
2013